Published in Metabolism on April 01, 2005
Exercise training and plasma C-reactive protein and interleukin-6 in elderly people. J Am Geriatr Soc (2008) 1.55
Effect of exercise training on chronic inflammation. Clin Chim Acta (2010) 1.52
Strength training improves muscle quality and insulin sensitivity in Hispanic older adults with type 2 diabetes. Int J Med Sci (2006) 1.52
A yearlong exercise intervention decreases CRP among obese postmenopausal women. Med Sci Sports Exerc (2009) 1.26
Short-term exercise improves beta-cell function and insulin resistance in older people with impaired glucose tolerance. J Clin Endocrinol Metab (2007) 1.16
Effects of interventions on oxidative stress and inflammation of cardiovascular diseases. World J Cardiol (2011) 1.11
Metabolic actions of insulin in men and women. Nutrition (2010) 1.07
Effects of aerobic and strength-based training on metabolic health indicators in older adults. Lipids Health Dis (2010) 1.01
Independent and combined effects of physical activity and weight loss on inflammatory biomarkers in overweight and obese older adults. J Am Geriatr Soc (2013) 0.96
Exercise-induced Signals for Vascular Endothelial Adaptations: Implications for Cardiovascular Disease. Curr Cardiovasc Risk Rep (2012) 0.95
Creatine monohydrate and conjugated linoleic acid improve strength and body composition following resistance exercise in older adults. PLoS One (2007) 0.94
Effects of different doses of physical activity on C-reactive protein among women. Med Sci Sports Exerc (2010) 0.92
No reduction in C-reactive protein following a 12-month randomized controlled trial of exercise in men and women. Cancer Epidemiol Biomarkers Prev (2008) 0.92
The effects of acute exercise on serum adiponectin and resistin levels and their relation to insulin sensitivity in overweight males. Eur J Appl Physiol (2006) 0.91
The Anti-Inflammatory Actions of Exercise Training. Am J Lifestyle Med (2007) 0.89
Increased proinflammatory and oxidant gene expression in circulating mononuclear cells in older adults: amelioration by habitual exercise. Physiol Genomics (2011) 0.86
Effects of chronic exercise training on inflammatory markers in Australian overweight and obese individuals in a randomized controlled trial. Inflammation (2013) 0.85
The effect of physical activity and physical fitness on plasma adiponectin in adults with predisposition to metabolic syndrome. Eur J Appl Physiol (2006) 0.84
Exercise Modulates Oxidative Stress and Inflammation in Aging and Cardiovascular Diseases. Oxid Med Cell Longev (2015) 0.83
Exercise training impacts the myocardial metabolism of older individuals in a gender-specific manner. Am J Physiol Heart Circ Physiol (2008) 0.83
Influence of physical activity and nutrition on obesity-related immune function. ScientificWorldJournal (2013) 0.82
Effects of interventions on adiponectin and adiponectin receptors. J Exerc Rehabil (2014) 0.79
Changes in body weight, C-reactive protein, and total adiponectin in non-obese women after 12 months of a small-volume, home-based exercise program. Clinics (Sao Paulo) (2013) 0.77
Effects of walking on low-grade inflammation and their implications for Type 2 Diabetes. Prev Med Rep (2015) 0.77
Enhanced insulin sensitivity after acute exercise is not associated with changes in high-molecular weight adiponectin concentration in plasma. Eur J Endocrinol (2009) 0.76
Metabolic profile response to administration of epigallocatechin-3-gallate in high-fat-fed mice. Diabetol Metab Syndr (2014) 0.76
Combined aerobic and resistance exercise is effective for achieving weight loss and reducing cardiovascular risk factors without deteriorating bone health in obese young adults. Ann Pediatr Endocrinol Metab (2013) 0.75
Adiponectin, Leptin and Objectively Measured Physical Activity in Adults: A Narrative Review. Malays J Med Sci (2016) 0.75
Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med (2008) 25.70
Pioglitazone for diabetes prevention in impaired glucose tolerance. N Engl J Med (2011) 4.28
Follow-up of glycemic control and cardiovascular outcomes in type 2 diabetes. N Engl J Med (2015) 3.67
Point: HOMA--satisfactory for the time being: HOMA: the best bet for the simple determination of insulin sensitivity, until something better comes along. Diabetes Care (2007) 3.28
Nutrient modification of the innate immune response: a novel mechanism by which saturated fatty acids greatly amplify monocyte inflammation. Arterioscler Thromb Vasc Biol (2010) 2.42
Autoantibodies to oxidized LDL and cardiovascular risk: the Framingham Offspring Study. Atherosclerosis (2006) 2.04
Exenatide suppresses postprandial elevations in lipids and lipoproteins in individuals with impaired glucose tolerance and recent onset type 2 diabetes mellitus. Atherosclerosis (2010) 1.80
Macrophage-secreted factors induce adipocyte inflammation and insulin resistance. Biochem Biophys Res Commun (2006) 1.74
Discrimination between obesity and insulin resistance in the relationship with adiponectin. Diabetes (2004) 1.58
Determining optimal approaches for weight maintenance: a randomized controlled trial. CMAJ (2009) 1.56
APPLE Project: 2-y findings of a community-based obesity prevention program in primary school age children. Am J Clin Nutr (2007) 1.37
Postprandial hyperlipidemia, endothelial dysfunction and cardiovascular risk: focus on incretins. Cardiovasc Diabetol (2011) 1.31
The duration of diabetes affects the response to intensive glucose control in type 2 subjects: the VA Diabetes Trial. J Diabetes Complications (2011) 1.29
Improvement of postprandial endothelial function after a single dose of exenatide in individuals with impaired glucose tolerance and recent-onset type 2 diabetes. Diabetes Care (2010) 1.23
Pioglitazone slows progression of atherosclerosis in prediabetes independent of changes in cardiovascular risk factors. Arterioscler Thromb Vasc Biol (2012) 1.22
Actos Now for the prevention of diabetes (ACT NOW) study. BMC Endocr Disord (2009) 1.15
Palmitic acid induces IP-10 expression in human macrophages via NF-kappaB activation. Biochem Biophys Res Commun (2007) 1.12
Does aggressive glycemic control benefit macrovascular and microvascular disease in type 2 diabetes? Insights from ACCORD, ADVANCE, and VADT. Curr Cardiol Rep (2012) 1.06
Sustainability of lifestyle changes following an intensive lifestyle intervention in insulin resistant adults: Follow-up at 2-years. Asia Pac J Clin Nutr (2009) 1.06
Rates and determinants of coronary and abdominal aortic artery calcium progression in the Veterans Affairs Diabetes Trial (VADT). Diabetes Care (2010) 1.05
Urinary excretion of three nucleic acid oxidation adducts and isoprostane F(2)alpha measured by liquid chromatography-mass spectrometry in smokers, ex-smokers, and nonsmokers. Free Radic Biol Med (2003) 1.04
Differential effects of metformin and troglitazone on cardiovascular risk factors in patients with type 2 diabetes. Diabetes Care (2002) 1.03
Quantification of 8-iso-prostaglandin-F(2alpha) and 2,3-dinor-8-iso-prostaglandin-F(2alpha) in human urine using liquid chromatography-tandem mass spectrometry. Free Radic Biol Med (2003) 1.03
Prediction of diabetes based on baseline metabolic characteristics in individuals at high risk. Diabetes Care (2013) 1.01
Ethnic differences in the relationship between adiponectin and insulin sensitivity in South Asian and Caucasian women. Diabetes Care (2008) 1.00
Association between IL-6 and the extent of coronary atherosclerosis in the veterans affairs diabetes trial (VADT). Atherosclerosis (2008) 0.98
Prevention of diabetes with pioglitazone in ACT NOW: physiologic correlates. Diabetes (2013) 0.97
Two-year follow-up of an obesity prevention initiative in children: the APPLE project. Am J Clin Nutr (2008) 0.97
Pioglitazone inhibits the expression of inflammatory cytokines from both monocytes and lymphocytes in patients with impaired glucose tolerance. Arterioscler Thromb Vasc Biol (2008) 0.97
Monte Carlo analysis of a new model-based method for insulin sensitivity testing. Comput Methods Programs Biomed (2008) 0.97
Functional and physiological effects of yoga in women with rheumatoid arthritis: a pilot study. Altern Ther Health Med (2009) 0.96
Improvements in insulin resistance with weight loss, in contrast to rosiglitazone, are not associated with changes in plasma adiponectin or adiponectin multimeric complexes. Am J Physiol Regul Integr Comp Physiol (2006) 0.93
Molecular and signaling mechanisms of atherosclerosis in insulin resistance. Endocrinol Metab Clin North Am (2006) 0.93
Design and clinical pilot testing of the model-based dynamic insulin sensitivity and secretion test (DISST). J Diabetes Sci Technol (2010) 0.92
Induction of monocyte differentiation and foam cell formation in vitro by 7-ketocholesterol. J Lipid Res (2002) 0.91
Peroxisome proliferator-activated receptor-alpha and atherosclerosis: from basic mechanisms to clinical implications. Cardiol Rev (2005) 0.91
Lipolysis of triglyceride-rich lipoproteins, vascular inflammation, and atherosclerosis. Biochim Biophys Acta (2011) 0.91
Ischemia/reperfusion unveils impaired capacity of older adults to restrain oxidative insult. Free Radic Biol Med (2009) 0.87
Transient and steady-state euglycemic clamp validation of a model for glycemic control and insulin sensitivity testing. Diabetes Technol Ther (2006) 0.86
Progression of vascular calcification is increased with statin use in the Veterans Affairs Diabetes Trial (VADT). Diabetes Care (2012) 0.84
Pioglitazone reduces inflammatory responses of human adipocytes to factors secreted by monocytes/macrophages. Am J Physiol Endocrinol Metab (2009) 0.84
Plasma adiponectin concentrations do not increase in association with moderate weight loss in insulin-resistant, obese women. Metabolism (2004) 0.83
Body mass index and waist circumference cutoffs to define obesity in indigenous New Zealanders. Am J Clin Nutr (2010) 0.83
The relationship between plasma adiponectin concentration and insulin resistance is altered in smokers. J Clin Endocrinol Metab (2006) 0.82
Peroxisome proliferator-activated receptor-alpha and atherosclerosis: from basic mechanisms to clinical implications. Cardiology (2004) 0.82
A new approach to design and implement a lifestyle intervention programme to prevent type 2 diabetes in New Zealand Maori. Asia Pac J Clin Nutr (2003) 0.81
The effect of intensive glucose lowering on lipoprotein particle profiles and inflammatory markers in the Veterans Affairs Diabetes Trial (VADT). Diabetes Care (2013) 0.81
Body mass index status is effective in identifying metabolic syndrome components and insulin resistance in Pacific Island teenagers living in New Zealand. Metabolism (2008) 0.80
A novel insulin resistance index to monitor changes in insulin sensitivity and glucose tolerance: the ACT NOW study. J Clin Endocrinol Metab (2015) 0.79
Intensive glycemic control and cardiovascular disease: are there patients who may benefit? Postgrad Med (2011) 0.79
Cardiovascular risk factors associated with insulin resistance in children persist into late adolescence. Diabetes Care (2005) 0.78
Clinical validation of the quick dynamic insulin sensitivity test. IEEE Trans Biomed Eng (2012) 0.78
The hypertriglyceridaemic waist in New Zealand Maori. Asia Pac J Clin Nutr (2004) 0.78
Follow-up of Glycemic Control and Cardiovascular Outcomes in Type 2 Diabetes. N Engl J Med (2015) 0.77
A spectrum of dynamic insulin sensitivity test protocols. J Diabetes Sci Technol (2011) 0.77
Acute exercise increases resistance to oxidative stress in young but not older adults. Age (Dordr) (2014) 0.77
Insulin resistance and impaired glucose metabolism in a predominantly Maori community. Diabetes Res Clin Pract (2005) 0.76
The identification of insulin saturation effects during the dynamic insulin sensitivity test. Open Med Inform J (2010) 0.75
Preliminary report: hepatic fat and inflammation in type 2 diabetes mellitus. Metabolism (2009) 0.75
Fetuin-A does not explain ethnic disparity in cardiometabolic risk factors and subclinical atherosclerosis between Hispanics and non-Hispanic whites. Metab Syndr Relat Disord (2010) 0.75
Exercise Redox Signaling: Intensity Matters: 2447 June 3, 9: 45 AM - 10: 00 AM. Med Sci Sports Exerc (2016) 0.75
A three-compartment model of the C-peptide-insulin dynamic during the DIST test. Math Biosci (2010) 0.75
Managing lipid disorders: further evaluation of the VA-HIT. Curr Diab Rep (2003) 0.75
Heart protection study: LDL lowering therapy and cardiovascular outcomes in patients with low cholesterol levels or diabetes. Curr Diab Rep (2002) 0.75